{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T11:17:02Z","timestamp":1788261422967,"version":"build-2803163510"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81873475"],"award-info":[{"award-number":["81873475"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81873719"],"award-info":[{"award-number":["81873719"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004826","name":"Natural Science Foundation of Beijing Municipality","doi-asserted-by":"publisher","award":["7212062"],"award-info":[{"award-number":["7212062"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.lfs.2022.120942","type":"journal-article","created":{"date-parts":[[2022,9,9]],"date-time":"2022-09-09T05:25:19Z","timestamp":1662701119000},"page":"120942","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Soluble epoxide hydrolase inhibitor, t-AUCB, improves salivary gland function by ameliorating endothelial injury"],"prefix":"10.1016","volume":"308","author":[{"given":"Wen-wen","family":"Han","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-rui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-feng","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han-shu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Cong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruo-Lan","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Ling","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guang-Yan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-mei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.lfs.2022.120942_bb0005","doi-asserted-by":"crossref","DOI":"10.14219\/jada.archive.2003.0018","article-title":"Xerostomia: etiology, recognition and treatment","volume":"134","author":"Guggenheimer","year":"2003","journal-title":"J. Am. Dent. Assoc."},{"issue":"4","key":"10.1016\/j.lfs.2022.120942_bb0010","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1111\/j.1469-445X.1999.01871.x","article-title":"Effects of reducing submandibular blood flow on secretory responses to parasympathetic stimulation in anaesthetized cats","volume":"84","author":"Hanna","year":"1999","journal-title":"Exp. Physiol."},{"issue":"5","key":"10.1016\/j.lfs.2022.120942_bb0015","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1152\/jappl.2000.89.5.1964","article-title":"Submandibular secretory and vascular responses to stimulation of the parasympathetic innervation in anesthetized cats","volume":"89","author":"Rourke","year":"2000","journal-title":"J Appl Physiol (1985)"},{"key":"10.1016\/j.lfs.2022.120942_bb0020","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/5584_2016_90","article-title":"Endothelial dysfunction and hypertension","volume":"956","author":"Konukoglu","year":"2017","journal-title":"Adv. Exp. Med. Biol."},{"issue":"2","key":"10.1016\/j.lfs.2022.120942_bb0025","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1007\/s00330-012-2606-z","article-title":"Magnetic resonance imaging to assess the effect of exercise training on pulmonary perfusion and blood flow in patients with pulmonary hypertension","volume":"23","author":"Ley","year":"2013","journal-title":"Eur. Radiol."},{"issue":"5","key":"10.1016\/j.lfs.2022.120942_bb0030","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1002\/jmri.21954","article-title":"Proximal femur bone marrow blood perfusion indices are reduced in hypertensive rats: a dynamic contrast-enhanced mri study","volume":"30","author":"Zhang","year":"2009","journal-title":"J. Magn. Reson. Imaging"},{"issue":"5","key":"10.1016\/j.lfs.2022.120942_bb0035","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/odi.12043","article-title":"Influence of hypertension on ph of saliva in older adults","volume":"19","author":"Kagawa","year":"2013","journal-title":"Oral Dis."},{"issue":"3","key":"10.1016\/j.lfs.2022.120942_bb0040","first-page":"190","article-title":"Does hypertension affect saliva properties?","volume":"21","author":"Mohiti","year":"2020","journal-title":"J. Dent. (Shiraz)"},{"issue":"7","key":"10.1016\/j.lfs.2022.120942_bb0045","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1111\/joor.12398","article-title":"Oral physiology, nutrition and quality of life in diabetic patients associated or not with hypertension and beta-blockers therapy","volume":"43","author":"Pereira","year":"2016","journal-title":"J. Oral Rehabil."},{"issue":"1","key":"10.1016\/j.lfs.2022.120942_bb0050","doi-asserted-by":"crossref","first-page":"14524","DOI":"10.1038\/s41598-017-15211-0","article-title":"Proteomic analysis reveals an impaired ca\/aqp5 pathway in the submandibular gland in hypertension","volume":"7","author":"Zhang","year":"2017","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.lfs.2022.120942_bb0055","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0217030","article-title":"Losartan and isoproterenol promote alterations in the local renin-angiotensin system of rat salivary glands","volume":"14","author":"Cano","year":"2019","journal-title":"PLoS One."},{"issue":"3","key":"10.1016\/j.lfs.2022.120942_bb0060","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/0306-3623(94)00195-S","article-title":"On the relation of calcium channel blockers to rat parotid and submandibular glands function in vivo","volume":"26","author":"Dehpour","year":"1995","journal-title":"Gen. Pharmacol."},{"issue":"6","key":"10.1016\/j.lfs.2022.120942_bb0065","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1111\/j.1600-0714.1994.tb00060.x","article-title":"Stimulated parotid salivary flow rates in normotensive, hypertensive, and hydrochlorothiazide-medicated","volume":"23","author":"Streckfus","year":"1994","journal-title":"J. Oral Pathol. Med."},{"key":"10.1016\/j.lfs.2022.120942_bb0070","first-page":"1","article-title":"Xerostomia: prevalence and pharmacotherapy. With special reference to beta-adrenoceptor antagonists","volume":"116","author":"Nederfors","year":"1996","journal-title":"Swed. Dent. J. Suppl."},{"issue":"10","key":"10.1016\/j.lfs.2022.120942_bb0075","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1161\/CIRCRESAHA.120.317015","article-title":"Angiotensin-converting enzyme 2: sars-cov-2 receptor and regulator of the renin-angiotensin system: celebrating the 20th anniversary of the discovery of ace2","volume":"126","author":"Gheblawi","year":"2020","journal-title":"Circ. Res."},{"key":"10.1016\/j.lfs.2022.120942_bb0080","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/bs.apha.2016.04.003","article-title":"Epoxyeicosatrienoic acids and 20-hydroxyeicosatetraenoic acid on endothelial and vascular function","volume":"77","author":"Imig","year":"2016","journal-title":"Adv. Pharmacol."},{"issue":"1\u20132","key":"10.1016\/j.lfs.2022.120942_bb0085","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.prostaglandins.2010.06.004","article-title":"14,15-epoxyeicosatrienoic acid induces vasorelaxation through the prostaglandin ep(2) receptors in rat mesenteric artery","volume":"93","author":"Yang","year":"2010","journal-title":"Prostaglandins Other Lipid Mediat."},{"issue":"1","key":"10.1016\/j.lfs.2022.120942_bb0090","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s12944-018-0780-y","article-title":"Soluble epoxide hydrolase inhibitors, t-aucb, downregulated mir-133 in a mouse model of myocardial infarction","volume":"17","author":"Gui","year":"2018","journal-title":"Lipids Health Dis."},{"issue":"9","key":"10.1016\/j.lfs.2022.120942_bb0095","doi-asserted-by":"crossref","first-page":"H1020","DOI":"10.1152\/ajpheart.00465.2014","article-title":"Soluble epoxide hydrolase inhibition improves coronary endothelial function and prevents the development of cardiac alterations in obese insulin-resistant mice","volume":"308","author":"Roche","year":"2015","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"6","key":"10.1016\/j.lfs.2022.120942_bb0100","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1177\/1479164119860215","article-title":"Impact of the acute local inhibition of soluble epoxide hydrolase on diabetic skin microcirculatory dysfunction","volume":"16","author":"Savina","year":"2019","journal-title":"Diab. Vasc. Dis. Res."},{"key":"10.1016\/j.lfs.2022.120942_bb0105","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.biopha.2018.02.126","article-title":"In renal hypertension, cirsium japonicum strengthens cardiac function via the intermedin\/nitric oxide pathway","volume":"101","author":"Yang","year":"2018","journal-title":"Biomed. Pharmacother."},{"issue":"11","key":"10.1016\/j.lfs.2022.120942_bb0110","doi-asserted-by":"crossref","DOI":"10.3390\/cells10113230","article-title":"High glucose reduces the paracellular permeability of the submandibular gland epithelium via the mir-22-3p\/sp1\/claudin pathway","volume":"10","author":"Huang","year":"2021","journal-title":"Cells."},{"issue":"6","key":"10.1016\/j.lfs.2022.120942_bb0115","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1161\/CIRCRESAHA.116.303587","article-title":"Hypertension: renin-angiotensin-aldosterone system alterations","volume":"116","author":"Te Riet","year":"2015","journal-title":"Circ. Res."},{"issue":"Suppl 3","key":"10.1016\/j.lfs.2022.120942_bb0120","first-page":"154","article-title":"Salivary flow in borderline hypertension","volume":"63","author":"Bohm","year":"1985","journal-title":"Klin. Wochenschr."},{"issue":"6","key":"10.1016\/j.lfs.2022.120942_bb0125","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/0030-4220(94)90321-2","article-title":"Comparison of stimulated parotid salivary gland flow rates in normotensive and hypertensive persons","volume":"77","author":"Streckfus","year":"1994","journal-title":"Oral Surg. Oral Med. Oral Pathol."},{"issue":"1","key":"10.1016\/j.lfs.2022.120942_bb0130","article-title":"Effect of angiotensin ii on parotid saliva secretion in conscious sheep","volume":"237","author":"McKinley","year":"1979","journal-title":"Am. J. Physiol."},{"issue":"2","key":"10.1016\/j.lfs.2022.120942_bb0135","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1152\/japplphysiol.00992.2002","article-title":"Effects of prolonged reduction in blood flow on submandibular secretory function in anesthetized sheep","volume":"95","author":"Thakor","year":"2003","journal-title":"J. Appl. Physiol. (1985)"},{"issue":"6","key":"10.1016\/j.lfs.2022.120942_bb0140","doi-asserted-by":"crossref","first-page":"R1468","DOI":"10.1152\/ajpregu.00215.2010","article-title":"Role of cytochrome p-450 metabolites in the regulation of renal function and blood pressure in 2-kidney 1-clip hypertensive rats","volume":"300","author":"Sporkov\u00e1","year":"2011","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"issue":"7","key":"10.1016\/j.lfs.2022.120942_bb0145","article-title":"Soluble epoxide hydrolase inhibitor t-aucb ameliorates vascular endothelial dysfunction by influencing the nf-\u03bab\/mir-155-5p\/enos\/no\/i\u03bab cycle in hypertensive rats","volume":"11","author":"Wang","year":"2022","journal-title":"Antioxidants (Basel, Switzerland)."},{"issue":"6","key":"10.1016\/j.lfs.2022.120942_bb0150","doi-asserted-by":"crossref","first-page":"3089","DOI":"10.1038\/s41596-021-00533-1","article-title":"Perfusion and endothelialization of engineered tissues with patterned vascular networks","volume":"16","author":"Kinstlinger","year":"2021","journal-title":"Nat. Protoc."},{"issue":"3","key":"10.1016\/j.lfs.2022.120942_bb0155","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1097\/FJC.0b013e318273b007","article-title":"Epoxyeicosatrienoic acid pathway in human health and diseases","volume":"61","author":"Bellien","year":"2013","journal-title":"J. Cardiovasc. Pharmacol."},{"issue":"2 Pt 2","key":"10.1016\/j.lfs.2022.120942_bb0160","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1161\/hy0202.103788","article-title":"Soluble epoxide hydrolase inhibition lowers arterial blood pressure in angiotensin ii hypertension","volume":"39","author":"Imig","year":"2002","journal-title":"Hypertension"},{"issue":"3","key":"10.1016\/j.lfs.2022.120942_bb0165","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1517\/17460441.2014.881354","article-title":"Design and discovery of soluble epoxide hydrolase inhibitors for the treatment of cardiovascular diseases","volume":"9","author":"Duflot","year":"2014","journal-title":"Expert Opin. Drug Discovery"},{"key":"10.1016\/j.lfs.2022.120942_bb0170","doi-asserted-by":"crossref","first-page":"420","DOI":"10.3389\/fphar.2019.00420","article-title":"Soluble epoxide hydrolase inhibitor: a novel potential therapeutic or prophylactic drug for psychiatric disorders","volume":"10","author":"Ren","year":"2019","journal-title":"Front. Pharmacol."},{"issue":"5","key":"10.1016\/j.lfs.2022.120942_bb0175","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1755-5922.2011.00282.x","article-title":"Evaluation of the effects of urotensin ii and soluble epoxide hydrolase inhibitor on skin microvessel tone in healthy controls and heart failure patients","volume":"30","author":"Tran","year":"2012","journal-title":"Cardiovasc. Ther."},{"issue":"6","key":"10.1016\/j.lfs.2022.120942_bb0180","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1097\/01.fjc.0000189600.74157.6d","article-title":"An epoxide hydrolase inhibitor, 12-(3-adamantan-1-yl-ureido)dodecanoic acid (auda), reduces ischemic cerebral infarct size in stroke-prone spontaneously hypertensive rats","volume":"46","author":"Dorrance","year":"2005","journal-title":"J. Cardiovasc. Pharmacol."},{"issue":"16","key":"10.1016\/j.lfs.2022.120942_bb0185","doi-asserted-by":"crossref","first-page":"8849","DOI":"10.1073\/pnas.96.16.8849","article-title":"Potent urea and carbamate inhibitors of soluble epoxide hydrolases","volume":"96","author":"Morisseau","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"5","key":"10.1016\/j.lfs.2022.120942_bb0190","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1111\/j.1476-5381.2011.01641.x","article-title":"Pharmacokinetics and in vivo potency of soluble epoxide hydrolase inhibitors in cynomolgus monkeys","volume":"165","author":"Ulu","year":"2012","journal-title":"Br. J. Pharmacol."},{"issue":"11","key":"10.1016\/j.lfs.2022.120942_bb0195","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1161\/01.RES.87.11.992","article-title":"Soluble epoxide hydrolase regulates hydrolysis of vasoactive epoxyeicosatrienoic acids","volume":"87","author":"Yu","year":"2000","journal-title":"Circ. Res."},{"issue":"6","key":"10.1016\/j.lfs.2022.120942_bb0200","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1016\/j.bmcl.2009.01.069","article-title":"Salicylate-urea-based soluble epoxide hydrolase inhibitors with high metabolic and chemical stabilities","volume":"19","author":"Kasagami","year":"2009","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"16","key":"10.1016\/j.lfs.2022.120942_bb0205","doi-asserted-by":"crossref","first-page":"3825","DOI":"10.1021\/jm070270t","article-title":"Orally bioavailable potent soluble epoxide hydrolase inhibitors","volume":"50","author":"Hwang","year":"2007","journal-title":"J. Med. Chem."},{"issue":"3","key":"10.1016\/j.lfs.2022.120942_bb0210","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.ejps.2010.03.018","article-title":"Pharmacokinetic screening of soluble epoxide hydrolase inhibitors in dogs","volume":"40","author":"Tsai","year":"2010","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.lfs.2022.120942_bb0215","article-title":"Soluble epoxide hydrolase inhibition prevents experimental type 4 cardiorenal syndrome","volume":"7","author":"Hamzaoui","year":"2020","journal-title":"Front. Mol. Biosci."},{"issue":"11","key":"10.1016\/j.lfs.2022.120942_bb0220","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.1161\/ATVBAHA.111.231050","article-title":"C1q\/tnf-related proteins, a family of novel adipokines, induce vascular relaxation through the adiponectin receptor-1\/ampk\/enos\/nitric oxide signaling pathway","volume":"31","author":"Zheng","year":"2011","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"5","key":"10.1016\/j.lfs.2022.120942_bb0225","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0217214","article-title":"Voluntary wheel running activates akt\/ampk\/enos signaling cascades without improving profound endothelial dysfunction in mice deficient in \u03b1-galactosidase a","volume":"14","author":"Kang","year":"2019","journal-title":"PLoS One."},{"issue":"7","key":"10.1016\/j.lfs.2022.120942_bb0230","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/s41440-021-00638-w","article-title":"The antihypertensive effect of mk on spontaneously hypertensive rats through the ampk\/akt\/enos\/no and erk1\/2\/cx43 signaling pathways","volume":"44","author":"Yu","year":"2021","journal-title":"Hypertens. Res."},{"issue":"1","key":"10.1016\/j.lfs.2022.120942_bb0235","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1074\/jbc.M111.261818","article-title":"Fat-derived factor omentin stimulates endothelial cell function and ischemia-induced revascularization via endothelial nitric oxide synthase-dependent mechanism","volume":"287","author":"Maruyama","year":"2012","journal-title":"J. Biol. Chem."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320522006427?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320522006427?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T21:07:28Z","timestamp":1758402448000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320522006427"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":47,"alternative-id":["S0024320522006427"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2022.120942","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Soluble epoxide hydrolase inhibitor, t-AUCB, improves salivary gland function by ameliorating endothelial injury","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2022.120942","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"120942"}}